OpenAI's GPT-5 aims to improve medical AI accuracy with retrieval‑augmented generation

OpenAI is developing GPT‑5 with a focus on medical applications, employing retrieval‑augmented generation (RAG) to ground responses in verified clinical databases rather than relying solely on training data. Experts note that such architecture can reduce hallucinations but stress that AI tools must remain supportive, requiring human oversight for diagnosis and patient‑specific nuances.

Regulatory bodies highlight two main hurdles: algorithmic bias that may affect under‑represented groups and strict data‑privacy compliance, such as HIPAA in the United States and GDPR in the European Union. Future medical AI systems are expected to expand beyond text to multimodal analysis, integrating imaging, genomics and real‑time biometric data, subject to standardized safety benchmarks before widespread clinical deployment.